LIVE WEBINAR SERIES

Embracing technology to help diagnose, treat and monitor Growth Disorders

WATCH THE on demand webinars

1st Webinar

2nd Webinar

Overview

Clinical examination and experience are key, but can be augmented by team support, genetic techniques and artificial intelligence (AI). The ability to accurately pinpoint the growth defect allows nuanced and personalized care for the patient and their family, and optimal height outcomes. Technology also features in patient management, in the form of apps and therapy adherence monitoring which have proven an increase in patient engagement and compliance with medication regimes. The two webinars will be live-streamed, with opportunities for the audience to ask questions and to interact with the Chair and presenters. After each live-stream, a recording of the webinar will be posted online and will be available globally as a free, open-access resource on the MedEA e-learning platform for up to a year after launch.

Learning Objectives

After attending the live webinars participants will be able to:

Target Audience

Pediatricians, endocrinologists and general practitioners involved in growth management.

Language

The official language of this live educational programme will be English. Simultaneous translation into Spanish and Korean will be provided.

Continuing Medical Education

The Artificial intelligence (AI) versus clinical skills in the investigation of short stature – Virtual, Italy, 21/06/2024 – 21/06/2024 has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 1.0 European CME credits (ECMEC®s).

The Digital technology and support for patients and healthcare professionals in the diagnosis and treatment of growth disorders – Virtual, Italy, 20/09/2024 – 20/09/2024 has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 1.0 European CME credits (ECMEC®s).

Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity. Through an agreement between the Union Européenne des Médecins Spécialistes and the American Medical Association, physicians may convert EACCME® credits to an equivalent number of AMA PRA Category 1 CreditsTM. Information on the process to convert EACCME® credit to AMA credit can be found at https://edhub.ama-assn.org/pages/applications.

Live educational activities, occurring outside of Canada, recognised by the UEMS-EACCME® for ECMEC®s are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.

uems-eaccme-logo

The content of the “Embracing Technology to Help Diagnose, Treat and Monitor Growth Disorders – Webinar: 21st June & 20th September 2024” has been certified by the CPD Certification Service as conforming to continuing professional development principles.

Embracing technology to help diagnose, treat and monitor Growth Disorders

Live Webinar Series
21 June 2024 · from 14.00 to 15.00 CEST

20 September 2024 · from 14.00 to 15.00 CEST

Faculty

Justin Davies

Justin Davies

Professor of Paediatric Endocrinology
University of Southampton
Southampton, UK
Paul Dimitri

Paul Dimitri

Professor of Child Health Technology at the University of Sheffield and
Professor of Child Health at Sheffield Hallam University
Consultant in Paediatric Endocrinology and Director of Technology & Innovation at the Sheffield Children’s NHS Foundation Trust UK
Sheffield, UK
Luis Fernandez-Luque

Luis Fernandez-Luque

Adhera Health Inc,
Santa Cruz, CA, USA
Martin O. Savage

Martin O. Savage

Emeritus Professor of Paediatric Endocrinology
William Harvey Research Institute
Barts and the London School of Medicine and Dentistry
Queen Mary, University of London, UK
Laura-Maria Peltonen

Laura-Maria Peltonen

Associate Professor
Department of Health and Social Management
University of Eastern Finland and Wellbeing Services County of North Savo
Turku, Finland
Richard JM Ross

Richard JM Ross

Professor of Endocrinology
University of Sheffield
Sheffield, UK

International Committee

Raúl Calzada León

Raúl Calzada León

President of the Latin-American Society of Pediatric Endocrinology (SLEP)
Head of the Endocrinology Service
National Institute of Pediatrics
Mexico City, Mexico
Ana Elena Chiesa

Ana Elena Chiesa

Coordinator of the International Relations Commission
Latin American Society of Pediatric Endocrinology (SLEP)
Pediatric Endocrinologist
Department of Pediatrics
R. Gutiérrez Children's Hospital
Buenos Aires, Argentina
María Isabel Hernández C.

María Isabel Hernández C.

Coordinator of the Continuing Education Committee of the Latin American Society of Pediatric Endocrinology (SLEP)
Pediatric Endocrinologist and Assistant Professor
Department of Neurological Sciences
Institute of Neurosurgery Asenjo
Faculty of Medicine
University of Chile
Santiago, Chile
Jeff Bolton

Jeff Bolton

Chair of Trustees
Child Growth Foundation
UK
Tabitha Randell

Tabitha Randell

Chair of the British Society for Paediatric Endocrinology and Diabetes (BSPED)
Consultant in Paediatric Endocrinology and Diabetes
Nottingham Children’s Hospital Nottingham, UK

Partnerships

Agenda

AGENDA

· Martin O. Savage ·

Martin Savage is Emeritus Professor of Paediatric Endocrinology at William Harvey Research Institute, Barts and the London School of Medicine & Dentistry, Queen Mary, University of London. He was head of the Paediatric Endocrine Unit at Barts and the London School of Medicine from 1982 to 2007. He has interests in growth disorders, specifically those with abnormalities in the GH-IGF-1 axis and in phenotype-genotype relationships of GH-IGF-1 axis defects, notably GH resistance. He published the first human case of an IGF-1 gene defect in the New England Journal of Medicine in 1996.  His other interests are Cushing’s syndrome and growth in chronic inflammatory diseases. He was General Secretary of the European Society for Paediatric Endocrinology (ESPE) from 1997 to 2004. He has lectured in 60 countries and has published 482 original articles, reviews, textbook chapters and books. In 2007, he was awarded the ESPE Andrea Prader Prize for contributions to paediatric endocrinology and in 2018 he received a Visionary Award from the American Human Growth Foundation. In 2022, he received a Research Excellence Award from the Dr Sulaiman Al Habib Medical Journal in Riyadh, and the British Society of Paediatric Endocrinology & Diabetes James M. Tanner Lifetime Achievement Award. He continues to lecture nationally and internationally.

· Justin Davies ·

Justin Davies is Professor of Paediatric Endocrinology at the University of Southampton, UK. Prof Davies research interests include growth and imprinting disorders (including Silver-Russell and Temple syndrome), secondary osteoporosis and care for children with differences of sex development. He Co-Chairs the British Society of Paediatric Endocrinology and Diabetes Growth Disorders Special Interest Group, and is developing a standardised national approach to growth assessment and management of growth hormone deficiency.

He is Chair of the international – DSD care quality committee. Prof Davies is member of the national NHS England service specification working group– developing national policy to optimise paediatric endocrine services and improve care. He is a Senior Editor for Endocrine Connections. Prof Davies leads the European Society for Paediatric Endocrinology, Winter School. He is a past Chair of the British Society of Paediatric Endocrinology and Diabetes 2016-2020.

· Paul Dimitri ·

Paul Dimitri BSc, MBChB, FRCPCH, PhD is a Consultant in Paediatric Endocrinology at Sheffield Children’s NHS Foundation Trust, Professor of Child Health Technology at the University of Sheffield, and Professor of Child Health at Sheffield Hallam University. He has worked in paediatrics since 1998 and paediatric endocrinology since 2004, with clinical expertise in disorders of growth, puberty, and hormone regulation. He leads the Hypothalamic and Pituitary Tumour Service and co‑leads the Paediatric Late Effects Endocrinology service supporting childhood cancer survivors with endocrine complications. His research spans child health technology, endocrinology, and skeletal development, and he is widely published in these fields. Professor Dimitri is Director of the NIHR HealthTech Research Centre in Paediatrics and Child Health and Clinical Director of the national TITCH Network, driving innovation in child health technology. He previously directed the NIHR CYP MedTech Cooperative, the UK’s first paediatric MedTech Co‑operative, and served as NIHR National Children’s Specialty Lead from 2016–2024. He is Vice President for Science and Research at the Royal College of Paediatrics and Child Health, shaping national research policy. In 2025, he was awarded NIHR Senior Investigator status, recognising his leadership in applied child health research and his commitment to transforming healthcare for children and young people.

· Luis Fernandez-Luque ·

Luis Fernandez-Luque PhD has two decades of experience in digital health research. He has participated in research on the area across Europe, Asia and the US. As Chief Scientific Officer at Adhera Health, he is actively involved in research aiming to bring evidence-based digital solutions to support families of children with chronic conditions, including families affected by growth hormone disorders, obesity and diabetes. He has over 80 publications on the topic of technologies to support people affected by chronic conditions and he is elected fellow of the International Academy of Health Sciences Informatics.

· Laura Maria Peltonen ·

Laura Peltonen is Associate Professor at the Department of Health and Social Management at the University of Eastern Finland and the Wellbeing services county of North Savo. Her research focuses on information management to support decision-making on different levels in health service provision. Her interests span from the development of user tailored intuitive solutions to applications of advanced technologies with a particular focus on the implementation process and measurement of the effects of these technologies in practice from the perspectives of organisational and patient outcomes. Dr. Peltonen earned her PhD in Nursing Science at the Department of Nursing Science at the University of Turku in 2018. She was granted the title of Docent in 2021 at the University of Turku. She is a Fellow of the European Academy of Nursing Science and the International Academy of Health Sciences Informatics. She is board member of the Finnish Social and Health Informatics Association and the European Federation for Medical Informatics. She chairs the Governance Advisory Panel of the Nursing Informatics Group of the International Medical Informatics Association. She teaches on bachelor, masters and doctoral levels in topics related to healthcare informatics, leadership and management in national and international uni- and interdisciplinary programs. She has authored and co-authored around one hundred peer-reviewed scientific articles and more than fifty additional articles intended for the professional community, ten book chapters and over twenty texts targeted at the general public: https://orcid.org/0000-0001-5740-6480. Her research has led to several instruments for the assessment of issues related to information management and leadership in healthcare and digital tools to support information use of primary and secondary use of health data.

· Richard JM Ross ·

Richard JM Ross trained in medicine at The Royal London Hospital (1974-1979) and in Endocrinology at St Bartholomew’s Hospital, London (1983-1988). Appointed to Sheffield University in 1995 and is Emeritus Professor of Endocrinology, past Head of Section and currently theme lead for Diabetes, Endocrinology and Metabolism. Retired from clinical practice in 2021. Richard’s research and clinical interests are in pituitary and adrenal disease, transition endocrinology and the late effects of cancer. Richard was Chief Scientific Officer and Director on the Board of Diurnal Group Plc (2004-2022); overseeing its flotation in 2015 on the London Stock market (AIM) prior to its purchase by Neurocrine Biosciences in 2022. Served on the editorial boards of: Clinical Endocrinology (1996-2000), Growth & Growth Factors (1986-2006), Hormones (2004-2018), and J Clin Endocrinol Metab (2010-2014). Council member for the Society of Endocrinology (1999-2002), Editor Endocrinologist (2001-2004), Chair of CaHASE (2002-2015), member of the Bioscientifica Board (2006-2010), Society for Endocrinology Public Engagement Committee (2008-2011) and Nominations Committee (2010-2012). Executive Committee of the European Society of Endocrinology (2011-2015), Treasurer of the European Society of Endocrinology (2013-2015), The Growth Hormone Research Society Council (2011-2018), and The Pituitary Society Board of Directors (2019-). Received The Endocrine Societies “Outstanding Innovation Award” in 2021 and awarded the Clinical

· Raúl Calzada León ·

Raúl Calzada León has been Chief of the Pediatric Endocrinology Service in the National Institute of Pediatrics, Mexico, since 1993. He was former President of the Mexican Society of Nutrition and Endocrinology and of the Mexican Society of Pediatric Endocrinology and is now the current President of the Latin-American Society of Pediatric Endocrinology. As well as clinical practice, Professor Calzada León is an active teacher and lecturer in endocrinology, pediatric endocrinology and clinical biochemistry at the National and Autonomous University of Mexico and the Medicine School at the National Polytechnic Institute of Mexico and advises nationally on Mexican health standards. He is a member of numerous national, regional and international societies for Endocrinology and Pediatrics. Professor Calzada León has published widely on many aspects of pediatric endocrinology, particularly on research into growth hormone treatment, congenital hypothyroidism, precocious puberty and early β-cell damage in pediatric patients with obesity and diabetes. He has been a member of the editorial board of Pediatric Endocrinology Review.

· Ana Elena Chiesa ·

Ana Elena Chiesa is Coordinator of the International Relations Commission of the Latin American Society of Pediatric Endocrinology (SLEP), Researcher at the CONICET (Consejo Nacional de Investigaciones Científicas y Técnicas) and at the GCBA research council, Attending Physician at the Division of Endocrinology, HNRG and Neonatal Screening (NBS) Program Medical Coordinator at the FEI (Fundación de Endocrinologia Infantil) and at the Buenos Aires City Government, Argentina. Doctor Chiesa is interested in the basic and clinical aspects of the thyroid axis. Her work is focused on thyroid disease during the neonatal period, childhood and adolescence. She carries on her research in different aspects related to neonatal screening (NBS) of inapparent diseases at birth such as Congenital Hypothyroidism, Congenital Adrenal Hyperplasia, and Phenylketonuria among others, taking care of the follow-up of patients.

· Maria Isabel Hernández C. ·

Professor Dr María Isabel Hernández is Pediatric Endocrinologist and Professor of Pediatric Endocrinology at the Department of Neurological Science, Institute of Neurosurgery Asenjo and Institute of Maternal and Child Research, Faculty of Medicine, University of Chile. Coordinator of the Continuing Education Committee the Latin American Society of Pediatric Endocrinology and Chilean Society of Endocrinology and Diabetes.

Prof. Hernández´s main research interest is pituitary disease and special focus in pituitary tumors and follow up of pediatric patients after brain tumors treatment. She leads the Pediatric endocrinology unit of pituitary disease in the Institute of Neurosurgery in Chile, which is a referral center for pituitary disease in the country.

· Jeff Bolton ·

A BSc (Hons) and MBA graduate from Welsh universities, Jeff joined the pharmaceutical industry in 1990. Jeff first worked for Janssen-Cilag, where he performed a number of commercial and marketing management roles.

Jeff joined Pfizer in 2002 as Senior Brand Manager in the Endocrinology Team and transitioned into a European marketing role in 2006. Jeff became European Brand Director in 2010. Jeff left Pfizer in 2016 to start his own consultancy company, JRB Consultancy Services Ltd.

Jeff has been involved with growth conditions for over 20 years, and has won numerous awards, both national and international, for his role in developing campaigns and support information and materials for families affected by growth conditions. Jeff was the European lead for the development of the first growth prediction tool, iGRO, which was sponsored by Pfizer, and has since been rolled out in more than 25 countries.

Jeff has been a trustee of the Child Growth Foundation for over two years and became their Chair in 2022.

· Tabitha Randell ·

Dr Tabitha Randell is a Consultant in Paediatric Endocrinology and Diabetes based at Nottingham Children’s Hospital, UK. She has over 25 years’ experience of working in paediatric diabetes and endocrinology, 20 years as a consultant, undergoing her training in both the UK and Australia. She is the current chair of the British Society for Paediatric Endocrinology and Diabetes (BSPED), elected in 2019 and taking up the role in 2020 following a year’s shadowing. She previously chaired the BSPED Clinical Committee from 2016-2020 and was the BSPED’s inaugural Media Officer from 2008-2012.

Join our Newsletter!

Stay in the know with our CME updates

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.